Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:121-126
Published online before print November 1, 2007, doi: 10.1161/ATVBAHA.107.152538
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/1/121    most recent
ATVBAHA.107.152538v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reilly, D. F.
Right arrow Articles by FitzGerald, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reilly, D. F.
Right arrow Articles by FitzGerald, G. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*EPINEPHRINE
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:121.)
© 2008 American Heart Association, Inc.


Cell Biology/Signaling

Peripheral Circadian Clock Rhythmicity Is Retained in the Absence of Adrenergic Signaling

Dermot F. Reilly; Anne M. Curtis; Yan Cheng; Elizabeth J. Westgate; Radu D. Rudic; Georgios Paschos; Jacqueline Morris; Ming Ouyang; Steven A. Thomas; Garret A. FitzGerald

From the Institute for Translational Medicine and Therapeutics (D.F.R., A.M.C., U.C., E.J.W., R.D.R., G.P., G.A.F.) and the Department of Pharmacology (J.M., M.O., S.A.T., G.A.F.), University of Pennsylvania, Philadelphia.

Correspondence to Garret A. FitzGerald, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, 153 Johnson-Pavilion, 3620 Hamilton Walk, Philadelphia, PA 19104-6084. E-mail garret{at}spirit.gcrc.upenn.edu

Abstract

Objective— The incidence of heart attack and stroke undergo diurnal variation. Molecular clocks have been described in the heart and the vasculature; however it is largely unknown how the suprachiasmatic nucleus (SCN) entrains these peripheral oscillators.

Methods and Results— Norepinephrine and epinephrine, added to aortic smooth muscle cells (ASMCs) in vitro, altered Per1, E4bp4, and dbp expression and altered the observed oscillations in clock gene expression. However, oscillations of Per1, E4bp4, dbp, and Per2 were preserved ex vivo in the aorta, heart, and liver harvested from dopamine β-hydroxylase knockout mice (Dbh–/–) that cannot synthesize either norepinephrine or epinephrine. Furthermore, clock gene oscillations in heart, liver, and white adipose tissue phase shifted identically in Dbh–/– mice and in Dbh+/– controls in response to daytime restriction of feeding. Oscillation of clock genes was similarly preserved ex vivo in tissues from Dbh+/– and Dbh–/– chronically treated with both propranolol and terazosin, thus excluding compensation by dopamine in Dbh–/– mice.

Conclusions— Although adrenergic signaling can influence circadian timing in vitro, peripheral circadian rhythmicity is retained despite its ablation in vivo.

We have examined the impact of adrenergic signaling on circadian timing in vascular tissues. Using vascular smooth muscle cells and dopamine β hydroxylase knockout mice we found that adrenergic signaling can influence circadian gene expression in vitro, but peripheral circadian rhythmicity is retained despite its ablation in vivo.


Key Words: circadian • catecholamines • norepinephrine • adrenergic • sympathetic




This article has been cited by other articles:


Home page
CirculationHome page
R. D. Rudic
Time Is of the Essence: Vascular Implications of the Circadian Clock
Circulation, October 27, 2009; 120(17): 1714 - 1721.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. E. Young
Anticipating anticipation: pursuing identification of cardiomyocyte circadian clock function
J Appl Physiol, October 1, 2009; 107(4): 1339 - 1347.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Su, Z. Guo, D. C. Randall, L. Cassis, D. R. Brown, and M. C. Gong
Hypertension and disrupted blood pressure circadian rhythm in Type 2 diabetic db/db mice
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1634 - H1641.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. Vujovic, A. J. Davidson, and M. Menaker
Sympathetic input modulates, but does not determine, phase of peripheral circadian oscillators
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R355 - R360.
[Abstract] [Full Text] [PDF]